Stacy Chin explains which NIH SBIR route to take: Phase 1, Phase 2, Direct-to-Phase 2, or Fast-Track. She breaks down each option so founders of biomedical startups can pick the right path for their technology's stage.
So I was on a call with a new client the other day, and he asked me, Stacy Chin, I'd like to submit an SBIR application to the National Institutes of Health. Should I go for a Phase I, a Phase II, a Direct-to-Phase II, or a Fast-Track SBIR application? And it had occurred to me that this is a very common question I get all the time, especially from founders developing new biomedical or healthcare-related technologies.
Applying for NIH SBIR in Jan 5, 2027? You Should Be Starting NOW. Here's why...
How to Get Invited to Apply for $305K in NSF SBIR Funding || Step-by-Step Guide
